The punishments follow a 2009 report by the European Commission on the pharmaceutical sector, which said ``pay-for-delay'' agreements between companies lead to consumers paying as much as 20 percent more for their medicines.
Punishments follow 2009 report by European Commission on pharmaceutical sector